CHL1 and glioma: In addition, CHL1, which is also negatively associated with long-term survival in GBM patients, promotes the survival of glioma cells by inhibiting the apoptosis of glioma cells via the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway [22].